Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium (A.P.).
Department of Vascular Medicine and Surgery, St. James's Hospital, Dublin, Ireland (C.C.).
Hypertension. 2021 Sep;78(4):898-911. doi: 10.1161/HYPERTENSIONAHA.121.17004. Epub 2021 Aug 30.
Renovascular hypertension is one of the most common forms of secondary hypertension. Over 95% of cases of renovascular hypertension are due either to atherosclerosis of the main renal artery trunks or to fibromuscular dysplasia. These two causes of renal artery stenosis have been extensively discussed in recent reviews and consensus. The aim of the current article is to provide comprehensive and up-to-date information on the remaining causes. While these causes are rare or extremely rare, etiologic and differential diagnosis matters both for prognosis and management. Therefore, the clinician cannot ignore them. For didactic reasons, we have grouped these different entities into stenotic lesions (neurofibromatosis type 1 and other rare syndromes, dissection, arteritis, and segmental arterial mediolysis) often associated with aortic coarctation and other arterial abnormalities, and nonstenotic lesions, where hypertension is secondary to compression of adjacent arteries and changes in arterial pulsatility (aneurysm) or to the formation of a shunt, leading to kidney ischemia (arteriovenous fistula). Finally, thrombotic disorders of the renal artery may also be responsible for renovascular hypertension. Although thrombotic/embolic lesions do not represent primary vessel wall disease, they are characterized by frequent macrovascular involvement. In this review, we illustrate the most characteristic aspects of these different entities responsible for renovascular hypertension and discuss their prevalence, pathophysiology, clinical presentation, management, and prognosis.
肾血管性高血压是最常见的继发性高血压类型之一。超过 95%的肾血管性高血压病例是由于主肾动脉主干的动脉粥样硬化或纤维肌性发育不良引起的。这两种肾动脉狭窄的原因在最近的综述和共识中已经得到了广泛的讨论。本文的目的是提供有关其余原因的全面和最新信息。虽然这些原因很少见或极为罕见,但病因和鉴别诊断对预后和管理都很重要。因此,临床医生不能忽视它们。出于教学目的,我们将这些不同的实体分为狭窄性病变(1 型神经纤维瘤病和其他罕见综合征、夹层、动脉炎和节段性动脉中层溶解),常与主动脉缩窄和其他动脉异常相关,以及非狭窄性病变,其中高血压继发于邻近动脉受压和动脉搏动性改变(动脉瘤)或形成分流导致肾缺血(动静脉瘘)。最后,肾动脉血栓形成性疾病也可能导致肾血管性高血压。尽管血栓/栓塞性病变不代表原发性血管壁疾病,但它们的特征是经常涉及大血管。在这篇综述中,我们说明了这些不同实体导致肾血管性高血压的最典型方面,并讨论了它们的患病率、病理生理学、临床表现、治疗和预后。